These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 32168519)
1. Spinal Muscular Atrophy in the Age of Gene Therapy. Williams L AACN Adv Crit Care; 2020 Mar; 31(1):86-91. PubMed ID: 32168519 [No Abstract] [Full Text] [Related]
2. Future avenues for therapy development for spinal muscular atrophy. Groen EJN Expert Opin Drug Discov; 2018 Oct; 13(10):899-902. PubMed ID: 30124076 [No Abstract] [Full Text] [Related]
12. Developing therapies for spinal muscular atrophy. Wertz MH; Sahin M Ann N Y Acad Sci; 2016 Feb; 1366(1):5-19. PubMed ID: 26173388 [TBL] [Abstract][Full Text] [Related]
13. The End of the Beginning: The Journey to Molecular Therapies for Spinal Muscular Atrophy. Pacak CA; Kang PB Pediatr Neurol; 2020 Jan; 102():1-2. PubMed ID: 31481328 [No Abstract] [Full Text] [Related]
14. More is needed to complement the available therapies of spinal muscular atrophy. Singh RN Future Med Chem; 2019 Nov; 11(22):2873-2876. PubMed ID: 31668092 [No Abstract] [Full Text] [Related]
15. Development of gene therapies-lessons from nusinersen. Xu L; Irony I; Bryan WW; Dunn B Gene Ther; 2017 Sep; 24(9):527-528. PubMed ID: 28737743 [TBL] [Abstract][Full Text] [Related]